Introduction
Genome-wide association study (GWAS) results represent a potentially rich source of information for etiological and treatment research that builds bridges between genome science and clinical and public health practice (Janssens 2008; Khoury, McBride, et al. 2009 ). Given the large number of such studies, sufficient GWAS data exist to support such translational research for a number of common chronic health conditions, including obesity Wray, Goddard, and Visscher 2007) . Infrastructure is already in place at the start of the translational pipeline, with GWAS data banked and curated in continuously updated searchable databases Yu et al. 2008) . Likewise, at the other end of the pipeline, evidence from translational research is evaluated to establish the clinical utility of genomic information and issue guidelines for clinical practice ). However, significant gaps remain in the middle of the translational pipeline, and approaches are needed to support research at this juncture, so that populationbased samples with rich environmental and phenotypic measurements can be used to follow up disease markers identified in GWAS. Specifically, systematic approaches are needed to sift the results of numerous association studies and distill the most promising set of markers for further investigation. These approaches must be able to harness the power of existing resources and flexibly accommodate the rapid rate of data discovery in genome science.
A key hurdle for research using GWAS results is that risky single-nucleotide polymorphisms (SNPs identified in GWAS may not cause adverse health outcomes but may instead be proxies for (i.e., correlated with) unmeasured disease-causing variation in the genome (Gibson and Goldstein 2007; Orozco, Barrett, and Zeggini 2010) . GWAS methods exploit linkage disequilibria (LD) across the genome to leverage the measurement of 100,000 to one million SNPs and capture variation in the 10 million-plus SNPs the genome is estimated to contain. The very large sample sizes in GWAS permit detection of risk associations even when proxy SNPs are in imperfect LD with disease-causing variation (correlation < 1). GWAS findings are generally applied to smaller samples designed to elucidate etiological and clinical correlates of discovered genes. When GWAS SNPs are translated to research using smaller samples, the measurement error resulting from imperfect LD with disease-causing variants can attenuate associations below levels these samples are powered to detect. Genetic risk scores (GRSs) summarize risk-associated variation across the genome (Horne et al. 2005 ) by aggregating information from multiple-risk SNPs (the simplest GRSs count disease-associated alleles). Because GRSs pool information from multiple SNPs, each individual SNP is less important to the summary measurement, and the "signal" from the GRS is robust to imperfect linkage for any one SNP. For the same reason, GRSs are less sensitive to minor allele frequencies for individual SNPs. As the number of SNPs included in a GRS grows, the distribution of values approaches normality, even when individual risk alleles are relatively uncommon (Fisher 1918) . Therefore, the GRS can be an efficient and effective means of constructing genome-wide risk measurements from GWAS findings. Downloaded by [Daniel W. Belsky] 
at 17:18 23 May 2013
Obesity is a public health problem that is well suited to risk assessment using a GRS. It is highly prevalent (Ogden et al. 2006) ; it is a significant source of health care costs, morbidity, and mortality (Adams et al. 2006; Allender and Rayner 2007; Trogdon et al. 2008) ; it is under strong genetic influence (Yang, Kelly, and He 2007) ; and GWAS are beginning to elucidate its molecular genetic roots (O'Rahilly 2009). Therefore, translational research in obesity genomics may ultimately help to address a public health priority. A key challenge in this effort is that obesity's genetic roots are diffuse, multifactorial, and nondeterministic; many variants scattered across the genome each contribute small risks for obesity (McCarthy 2010) . In other words, information from multiple genetic variants is needed to characterize genetic susceptibility to obesity. Thus, a GRS may be useful. A further challenge is uncertainty about the specific genetic variants that should be included in an obesity GRS. Different GWAS identify different genomic loci, and when loci are replicated across GWAS, the specific SNPs identified may be different (Hindorff et al. 2010) . To address this challenge, we developed a three-stage approach to review GWAS results and select specific SNPs to include in a GRS. We devised our approach to be systematic and replicable and to leverage the discovery potential of GWAS while minimizing the risk of including false-positive markers. In this article, we describe this three-stage approach, apply it to develop a GRS for obesity, and test the GRS as a measure of obesity risk using data from the population-based Atherosclerosis Risk in the Communities (ARIC) Study.
Methods

Sample
The ARIC sample is described in detail elsewhere (Folsom et al. 2006; ARIC Investigators 1989) . Briefly, ARIC is a prospective epidemiologic cohort study sponsored by the National Heart, Lung, and Blood Institute to investigate the etiology of atherosclerotic disease. The study draws from four U.S. communities: Minneapolis, Minnesota; Washington County, Maryland; Forsyth County, North Carolina; and Jackson, Mississippi. Participants were examined first during [1987] [1988] [1989] , and then during three subsequent periods (1990-1992, 1993-1995, and 1996-1998) , with ongoing follow-up conducted annually by telephone. ARIC cohort genotype data from the Affymetrix Affy 6.0 Chip and selected phenotypes were obtained for this study from the NIH database of Genotypes and Phenotypes (dbGaP).
The original ARIC sample includes 15,792 participants (27% African American, 55% female). The publicly available dataset obtained from dbGaP for this study includes genotype and phenotype data for 12,771 individuals. Of this sample, 1,212 participants had a missing call rate that was greater than 2 percent for SNPs called successfully in greater than or equal to 95 percent of the sample and were excluded from subsequent analyses, following the quality control recommendations of the GENEVA ARIC Project (GENEVA ARIC Project 2009). In addition, although the ARIC study design did not aim to include relatives, genomic analysis by the ARIC investigators revealed familial relationships at the level of half-siblings or closer among 1,674 participants. One member was selected at random from each of the 105 "families" uncovered by this investigation to form a sample of unrelated persons. After these exclusions, the sample consisted of 10,745 participants (23% African American, 55% female, hereafter referred to as the "analysis sample"). Downloaded by [Daniel W. Belsky] at 17:18 23 May 2013
Body Mass Index and Obesity
Body mass index (BMI) was calculated using measurements of weight rounded to the nearest pound and height rounded to the nearest centimeter. Obesity was defined as a BMI greater than or equal to 30, according to the criteria established by the U.S. Centers for Disease Control and Prevention. Anthropometric measurements were collected from participants wearing a scrub suit and no shoes at the four in-person data collection sessions.
Genotypes
Details on the genotyping of the ARIC sample are available through dbGaP and are described in detail elsewhere ). Briefly, genotyping was conducted by the Broad Institute using the Affymetrix Affy 6.0 SNP array and the Birdseed calling algorithm (Korn et al. 2008) . Following guidelines for the use of genotypic data provided by the ARIC GWAS team, data were extracted for all SNPs with a sample-wide call rate greater than or equal to 95 percent, with fewer than five discordant calls across duplicated DNA samples in the quality-control subsample (n = 334) and in Hardy-Weinberg Equilibrium (p > .001).
Genetic Risk Scores
Current mid-pipeline translational studies use either a "best-guess" approach or a "top-hits" approach to select genetic markers to include in GRSs. The best-guess approach selects markers identified in association studies that are located in or near genes with plausible biological relationships to the pathophysiology of a phenotype or that demonstrate strong and replicable association signals (Lyssenko et al. 2008; Morrison et al. 2007; Talmud et al. 2010) . The top-hits approach selects those markers with the strongest association signals in a single GWAS, independent of their biological plausibility (Demirkan et al. 2010; He et al. 2010) . Early studies have illustrated the promise of translational research with GWAS markers, but as the field moves forward, more systematic approaches are needed that can better integrate new information from the latest studies. Neither the tophits nor the best-guess approach provides a systematic and replicable means of integrating results from multiple GWAS. Meta-analysis can accomplish this integration, but comprehensive meta-analyses are not always available. Moreover, the top-hits and best-guess approaches do not provide a means to select specific SNPs for follow-up, and this problem is not solved by meta-analysis. The approach of selecting the "lead" SNP at a locususually the SNP with the lowest p value in the largest GWAS-is problematic, because different GWAS can report different lead SNPs for the same locus because of differences in GWAS chips, genotyping quality, and data-handling and analysis decisions. Thus, an approach is needed that facilitates systematic and replicable SNP selection from results of multiple GWAS.
Our three-stage approach integrates public-access resources including continuously updated databases of GWAS results, Web-based whole-genome analysis tools, and genome-wide data to identify the most promising set of SNPs for follow-up. Most important, the three-stage approach addresses key limitations of the top-hits and bestguess approaches, providing a systematic and replicable means of integrating findings across multiple GWAS and selecting SNPs for follow-up in new samples. The three stages are: Downloaded by [Daniel W. Belsky] at 17:18 23 May 2013
1. Extraction. All SNPs associated with one of the selected phenotypes at a given significance threshold are "extracted" from each GWAS and retained for further analysis. 2. Clustering:.Extracted SNPs are "clustered" according to patterns of LD that are determined from a reference population that matches the population in the GWAS included in Stage 1. Clustering yields a set of "LD blocks." 3. Selection. Statistical significance and replication are evaluated at the level of the LD block. The original GWAS results are used to assign a minimum p value and a replication count for each LD block. The minimum p value is the lowest p value reported for any SNP in the LD block in any GWAS contributing data in Stage 1. The replication count is the number of GWAS that reported an association for any SNP in the LD block at the threshold defined in Stage 1.
We applied our three-stage approach to construct two GRSs for obesity. First, we considered only GWAS published in print or online through December 31, 2008. We chose these GWAS because they were used in previous research that created top-hits and bestguess obesity GRSs. Thus, we used these GWAS to construct a GRS using our three-stage approach and then compared it to two previously published GRSs . Second, we considered all GWAS published through December 31, 2010. We applied our three-stage approach to the results from the full set of GWAS and compared the resulting GRS to a top-hits GRS generated from the largest meta-analysis of BMI GWAS published to date , as well as to a best-guess GRS generated from the full set of obesity-associated SNPs reported in the National Human Genome Research Institute (NHGRI) GWAS Catalog (Hindorff et al. 2010) . The derivation of the GRS using the three-stage approach is described in detail in the supplemental material (see Supplemental Methods and Supplemental Tables 1-7 ). Analyses (also described in the supplemental material) revealed that the three-stage approach created GRSs that were at least as predictive of BMI and obesity as GRSs created with the top-hits and best-guess approaches. Further analyses to refine the GRS created through the three-stage approach yielded a final set of 32 SNPs. We applied two weighting schemes to the 32 SNPs before summing them to create our obesity GRS: (1) equal weighting, under which the score was a simple count of BMI-increasing alleles; and (2) effect-size weighting, under which BMI-increasing alleles were weighted by the effect size reported for that locus in the GIANT Consortium or the DeCode BMI GWAS ). Effect-size weights were adjusted for LD between the SNP tested in the GWAS and the SNP genotyped in the ARIC sample. Each of the 32 SNPs in the GRS was missing for fewer than 1 percent of participants in any gender/ethnicity cell. GRSs were prorated by dividing the GRS by the number of SNPs contributing data and then multiplying by 32. The SNPs included in the final obesity GRS, their BMI-increasing ("effect") alleles, nearby genes, and weights are reported in Table 1 .
Evaluation of the Obesity GRS
Associations between the GRS and obesity-related traits (BMI, weight, waist circumference, obesity) were tested with linear and logistic regression models. These and subsequent models were adjusted for demographic and geographic control variables: age was specified as a linear and a quadratic term; a product term was included for the interaction between age and sex to account for sex differences in BMI and obesity distributions at different ages; and the four ARIC Study Centers where participants were enrolled in the study were Downloaded by [Daniel W. Belsky] Notes: Alleles are reported from the forward strand. The GRS was computed by counting the number of effect alleles at each SNP, multiplying that number by the SNP's weight, and then summing the results across the set of 32 SNPs. Weights reflect per-allele changes in BMI estimated in the the GIANT Consortium GWAS meta-analysis , except for rs867559, for which the weight was estimated in the DeCODE GWAS meta-analysis entered as a series of dummy variables (this collection of variables is referred to hereafter as "demographics and geography"). Predictiveness of the GRS was evaluated using three metrics that are established tools for evaluating risk markers in general (McGeechan et al. 2008) , as well as for evaluating the specific case of genetic risk scores (Mihaescu et al. 2010 ). The first metric was R 2 , the proportion of variation explained in BMI. The second metric used was AUC, the area under the receiver-operating characteristic (ROC) curve for obesity, also known as the discrimination index. R 2 was estimated using demographics and geography-adjusted linear regression models. The AUC corresponds to the probability that a randomly selected obese case will have a higher GRS than a randomly selected nonobese control. A marker that discriminates no better than chance has an AUC of 0.50. A marker that discriminates perfectly has an AUC of 1. A related metric is the partial AUC (PAUC), which sets a specificity threshold and calculates an AUC-like statistic for that specificity. Analyses of PAUC for the GRS set specificity at 80 percent (the bottom fifth of the ROC curve). AUC and PAUC analyses were stratified by the ARIC Study Center using Pepe's method ). To determine whether the GRS improved discrimination over and above demographic and geographic information, we calculated a second set of statistics, delta AUC and delta PAUC. Probit regression models were used to generate predicted probabilities of obesity for each ARIC participant using a baseline model that included demographic and geographic information and a test model that also included the GRS. AUCs were calculated using these predicted probabilities as "risk scores" (Pepe, Cai, and Longton 2006) , and estimates of the differences between the baseline and test models were bootstrapped to obtain confidence intervals. AUC analyses were conducted using the Stata package "comproc" 3) The third and final metric used was the integrated discrimination index (IDI) for obesity. The IDI evaluates the added predictiveness of a marker by comparing predictions made using a baseline set of risk markers to predictions that also include information about the new risk marker: IDI = Prob test, obese − Prob test,non−obese − Prob baseline, obese − Prob baseline, non−obese where "Prob" is the average predicted probability for a particular group from a particular model. The IDI measures change in model sensitivity net of change in model specificity and is a more sensitive measure than delta AUC ). An IDI of zero indicates that the test model performs comparably to the baseline model. Positive IDI values index net improvement in model sensitivity. Baseline and test models for IDI analyses were identical to those used in delta AUC analyses.
We tested differences between the predictiveness metrics for different risk scores by bootstrapping confidence intervals around the R 2 and AUC metrics (comparing the difference in estimated metric values across 1,000 random samples drawn with replacement from the ARIC database; see Pepe, Longton, and Janes 2009) and by applying Pencina's method to test change in the IDI metric. Comparisons were as follows: unweighted GRS versus weighted GRS; weighted GRS versus simple genetic risk assessment (the sum of risk alleles at the two best-replicated obesity loci: rs9939606, found in the gene FTO, and rs12970134, found downstream of the gene MC4R); weighted GRS versus socioeconomic index (educational attainment measured in six categories: grade school or less, some high school, high school graduate, vocational school, college, and graduate/professional school; information can be found in Supplementary 
Results
Obesity risk-allele distributions were similar for males and females but different for whites and African Americans. The variance of the unweighted GRS was greater for whites as compared to African Americans (SD = 3.50, as compared to 3.25, p < .001, using Brown and Forsythe's method; , as was the mean (M = 28.80, as compared to 24.87, p < .001, using a t-test for unequal variances; see also Supplementary Figure 1 , available from the authors on request). This difference reflected lower frequencies of BMI-increasing alleles for several GRS SNPs among African American ARIC participants (see Table 1 ). Subsequent analyses were stratified by race.
The obesity GRSs were weakly but consistently associated with BMI and the probability of being obese among whites and African Americans, but associations were weaker among African Americans (see Figure 1 ). Among whites, after adjusting for age, sex, and geography, the unweighted GRS was associated with BMI at r = 0.12, and the weighted GRS was associated with BMI at r = 0.13 (p < 1 × 10 −26 for both). This effect size corresponded to a 0.60-unit increase in BMI per standard deviation increase in the GRS. For each standard deviation increase in their unweighted and weighted GRSs, white ARIC participants' risk for obesity increased by 19.35 percent and 20.51 percent, respectively (p < 1 × 10 −18 for both). Among African Americans, the weighted and unweighted GRSs were associated with BMI at r = 0.05 (p < .05 for both). For each standard deviation increase in their unweighted and weighted GRSs, African American ARIC participants' risk for obesity increased by 3.54 percent (p = .059) and 4.92 percent (p = .017), respectively. Results were substantively unchanged when control variables were removed from the models. Although we stratified our analyses by ethnicity (whites and blacks), we conducted an additional analysis to determine whether population stratification within the white and black subsamples influenced our estimates of GRS-BMI or GRS-obesity associations. Principal components derived from eigen analysis of genome-wide SNP data can be used to control for population stratification in genetic association analyses . Such principal components were derived separately for whites and blacks in the ARIC cohort using the method described by Patterson, Price, and Reich ( 2006) and were included in the database we obtained from dbGaP (GENEVA ARIC Project 2009). Adjustment for these principal components as covariates in regression analyses did not change our results.
We conducted a series of additional sensitivity analyses to evaluate heterogeneity in GRS associations (described in detail in the supplementary material, available from the authors on request). These analyses supported a linear association between the GRS and BMI, showed that GRS-BMI associations were similar to GRS-weight and GRSwaist circumference associations, and revealed no sex or age differences in GRS-BMI associations.
The obesity GRSs performed similarly on the three predictiveness metrics (see Table 2 ). The top panel of Notes: The simple genetic risk score is a component of the weighted obesity genetic risk scores. Values of R 2 were estimated using linear regression models adjusted for demographics and geography. Percentile-based confidence intervals were generated using the bootstrap method. AUCs and percentile-based confidence intervals were estimated from ROC curves constructed for raw values (i.e., actual values of the measures tested, rather than predicted values generated from a regression model) and were adjusted for the geography where data were collected. IDIs and test statistics were estimated using comparisons of a baseline model that included demographic and geographic information to a test model that included both this information and the GRS.
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for the unweighted and weighted GRSs. Among whites, weighted and unweighted obesity GRSs explained small but statistically significant proportions of the variance in BMI (R 2 ), discriminated obese from nonobese participants modestly better than chance (AUC), and contributed small net improvements to the sensitivity of an obesity prediction model over and above demographic and geographic information (IDI). Among African Americans, the GRS did not contribute to the explanation of variance in BMI over and above demographic and geographic information, to the discrimination of obese from nonobese participants, or to the net sensitivity of the obesity prediction model. Use of weights derived from BMI GWAS improved the performance of the GRS among whites and African Americans, but this improvement was not statistically significant (p > .10 for all comparisons).
The bottom panel of Table 2 addresses research utility, presenting predictiveness metrics for two comparison measures of obesity risk: the simple genetic risk assessment (weighted combinations of rs9939609 in FTO and rs12970134 downstream of MC4R) and the socioeconomic index (a six-category measure of educational attainment). The FTO and MC4R loci and socioeconomic status are robust correlates of BMI and obesity in adult samples (Ford and Mokdad 2008; Hardy et al. 2010) . Comparison of the 32-locus GRS to a two-locus risk assessment can illustrate whether the GRS offers value added over a simpler genetic risk assessment. Comparison of the GRS to socioeconomic status can illustrate how the predictiveness of the GRS compares to the predictiveness of a social determinant of obesity that is not easily changed but is understood to be important in etiological research (Drewnowski 2009 ). Among whites, the genetic risk scores performed better than the comparison measures of obesity risk on all three metrics (p < .01 for all comparisons). Among African Americans, the GRSs performed no differently than the simple genetic risk assessment (p > .10) and performed less well than the socioeconomic index (p = .021). When combined with the comparison risk measures and demographic and geographic information, the GRS improved predictiveness for whites but not for African Americans (see Supplementary Table 9 , available from the authors on request). Figure 2 shows the model-based ROC curves for a baseline model that included demographic and geographic information and a test model that also included the weighted GRS. The change in AUC from the baseline model to the test model was greater than zero (delta AUC = 0.048, 95% CI = 0.313-0.658, p < 10 −7 ), indicating that the GRS improved discrimination of obese cases. This improvement in discrimination was concentrated at low specificities but did extend to the portion of the ROC curve that is of greatest interest to clinicians. At a specificity of 0.8, the test model including the GRS was marginally more sensitive than the baseline model (delta PAUC = 0.007, 95% CI < 0.0003-0.010, p <.001).
Results for African Americans are presented in Supplementary Figure 2 (available from the authors on request).
Discussion
We used a three-stage approach to construct an obesity GRS from GWAS results. Our tests of this obesity GRS in the population-based ARIC cohort revealed it to be a highly statistically significant predictor of BMI, as measured at four time points across 10 years; weight and waist circumference; and obesity. In terms of value added, the GRS improved prediction of BMI and obesity over and above demographic and geographic information, FTO and MC4R genotypes, and information about socioeconomic status. Thus, the GRS provides a measure of genetic predisposition to obesity that could inform etiological and treatment research. Receiver-operating characteristic (ROC) curves for obesity among white ARIC participants (n = 8,286). Baseline model = gender, age (quadratic), gender-age interaction, ARIC Study Center; Test Model = baseline model + weighted obesity genetic risk score. ROC curves were constructed using predicted values from probit regressions of obesity (BMI ≥ 30) on the model terms. Delta AUC (AUC Test -AUC Baseline ) = 0.048, 95% CI = 0.031-0.066, p < 1 × 10 −7 . Delta PAUC at 80% specificity = 0.007, 95% CI = 0.003-0.010, p < .001. AUCs, PAUCs, and delta AUCs were estimated using Pepe's method ).
The research utility of the GRS is likely limited to samples of European descent. GRS-BMI and GRS-obesity associations for African American ARIC participants were much smaller than comparable associations for white ARIC participants. Although the sample included fewer African Americans than whites, power to detect effects of equal size as those observed in whites was well over 80 percent in the African American sample. Moreover, effect-size measures (r, R 2 , relative risk, AUC, IDI) showed little evidence that the GRS predicted BMI or obesity among African Americans. These results suggest caution in using GWAS of European-descent populations to derive GRSs for African Americans. Our analyses did indicate that the GRS performed similarly among men and women. However, emerging evidence for gene-sex interactions in obesity (Benjamin et al. 2011; Heid et al. 2010) suggests that future obesity GRSs may require sex-specific construction.
Our results have implications for theory, research, and clinical practice. With respect to theory, our results are consistent with the hypothesis that genetic risk for obesity is quantitatively distributed and can be operationalized in a GRS (Plomin, Haworth, and Davis 2009) . With respect to research methods, our findings illustrate one approach to operationalize quantitative genetic risk. A systematic and replicable approach to selecting SNPs from association studies to follow-up on etiological and treatment research will be especially important with the advent of next-generation sequencing approaches. Nextgeneration sequencing is likely to uncover many new disease-associated loci for obesity, as well as for other phenotypes of interest to clinicians and researchers. These variants, though rarer in the population, may have higher penetration and thus greater clinical relevance. Downloaded by [Daniel W. Belsky] 
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Future research can also make use of the GRS derived in this study as a measure of inherited obesity risk. With respect to clinical practice, results indicate that for persons in middle age, GWAS SNP-based approaches to obesity risk assessment offer little in the absence of more detailed information about lifestyle and environment. Although genetic information reliably predicted risk for obesity over and above demographics and geography, the magnitude of this additional risk was insufficient to recommend our score for use in clinical risk assessments. This finding is especially important in the context of questions regarding consumer genomics services (Evans et al. 2011) . Our three-stage approach produced a more comprehensive genetic risk assessment for obesity than those currently produced by companies marketing genomics services directly to consumers. The very modest risk information furnished by our GRS recommends that health professionals be cautious in interpreting risk information provided by consumer genomics companies. The standard of evidence used here-multimethod assessment of predictiveness in large, population-based samples-should be considered a minimum standard for determining the validity of such risk information.
Results should be considered in light of the following limitations. First, some ARIC participants were included in the samples of some of the GWAS used to construct the GRS. However, these ARIC participants represented a minority of the GWAS samples, and results in the ARIC sample are similar to results from samples not included in any of the GWAS . Second, some risk loci identified by our three-stage approach could only be genotyped in the ARIC sample using relatively weak proxies. Given the small improvement to predictiveness associated with each additional SNP included in the GRS, it is unlikely that this limitation influenced the substance of our results, but it is possible that our GRS is moderately more predictive than analyses in the ARIC cohort suggest. Third, our analyses were limited to African Americans and white Americans. The ARIC cohort does not contain Asian or Hispanic individuals. It remains unclear whether the relatively greater similarity between these and European populations (Jorde and Wooding 2004) would support the generalization of our GRS. However, GWAS of Asian and Hispanic samples (He et al. 2010; Norris et al. 2009 ) suggest that a European-descent population-derived GRS may omit important risk loci for these populations. As more GWAS of non-European populations become available, our threestage approach can be used to derive additional population-specific GRSs. Fourth, there is mounting evidence that many genetic factors predisposing individuals to obesity are sexspecific (McCarthy et al. 2003) , and that GWAS that fail to model such sex-specificity may not detect important risk variants (McCarthy 2007) . Results from GWAS modeling genesex interaction support this hypothesis (Benjamin et al. 2011; Chiu et al. 2010; Heid et al. 2010) . As more such GWAS become available, our three-stage approach can be used to derive sex-specific GRSs for obesity. Finally, the ARIC sample is limited to individuals in middle age. There is evidence that genetic risk for obesity has dynamic consequences throughout development Sovio et al. 2011 ). It will be important in subsequent investigations to evaluate our obesity GRS in longitudinal cohorts that capture a broader section of the life course, and particularly in young people, as they are a key prevention target (Belsky et al. 2012; Dietz 2004) .
In this study, we constructed a GRS for obesity and showed that it predicted BMI and obesity in a population-based sample of middle-aged adults. These associations suggest that future research into obesity etiology and treatment can make use of genetic information. However, our analyses do not support the use of genetic testing for individual-level obesityrisk prediction. Future research with this GRS should characterize the expression of genetic Downloaded by [Daniel W. Belsky] 
Supplement
This supplement describes the application of the 3-stage approach to create a genetic risk score (GRS) for obesity. The supplement is organized into 3 sections: The first section describes the creation of the obesity GRS: Stage 1. Extraction; Stage 2. Clustering; and Stage 3. Selection. The second section describes analyses comparing the resulting GRS to GRSs created with the best-guess and top-hits approaches. The final section describes sensitivity analyses to test heterogeneity in GRS associations.
PART 1. CREATING THE OBESITY GRS Stage 1. Extraction
For our 3-stage approach analyses, we considered GWAS of European-descent samples that targeted 4 phenotypes: obesity, weight, waist circumference, and body mass index (BMI) (hereafter "obesityrelated phenotypes"). A search of the NGHRI GWAS Catalog using the HuGE Navigator (http://www.hugenavigator.org) identified 16 GWAS that met these inclusion criteria, 9 of which were published by December 31, 2008 (Supplementary Table 1 ).
In Stage 1 (Extraction), we compiled association results reported in the manuscripts and supplementary materials of the GWAS and extracted rs-numbers and p-values for SNPs associated with any of the 4 phenotypes in the discovery or combined discovery and replication samples at an alpha level of 1x10 -5 (n=103 SNPs in the subset of 9 GWAS, n=519 SNPs in the full set of 16 GWAS, Supplementary Table 2 ).
The significance level of p<1x10 -5 was the most generous threshold at which most GWAS published results and is the threshold used in the NHGRI GWAS Catalog ). Associations were not extracted from replication samples because few GWAS reported novel associations identified in replication samples and some GWAS did not include replication samples or included replication samples of different ethnicity. Discovery sample risk SNPs that failed to replicate within an individual GWAS were included because replication was evaluated at the level of the GWAS publication rather than the specific test sample.
Stage 2. Clustering
In Stage 2 (Clustering), we grouped the extracted SNPs into "LD blocks." We defined LD blocks using data from the HapMap CEU sample (Phase 3), queried using Seattle SNPs' web-based Genome Variation Server (http://gvs.gs.washington.edu/GVS). For each SNP extracted in Stage 1 ("seeds"), we defined an LD block as the region containing all SNPs in LD with that seed at a threshold of R 2 ≥0.95. Then, beginning Supplement to Development & Evaluation of a Genetic risk score for Obesity DW Belsky et al. with the block closest to the start of each chromosome, we pruned blocks that did not contain a unique seed. This process yielded n=66 LD blocks from the subset of 9 GWAS published by December 31, 2008 and n=158 LD blocks from the full set of 16 GWAS.
Stage 3. Selection
In Stage 3 (Selection), we retained LD blocks that we classified as genome-wide significant or as replicated. Genome-wide significant LD blocks were those that contained ≥1 SNP associated with an obesity-related phenotype at p<1x10 -8
. Replicated blocks were those that contained SNPs extracted from ≥2 GWAS. This process yielded n=37 LD blocks clustered around 11 loci on chromosomes 1-4,9,11,12,16,18, and 19 from the subset of 9 GWAS and n=69 LD blocks clustered around 32 loci on chromosomes 1-6,9, [11] [12] [13] [14] 16, 18 , and 19 from the full set of 16 GWAS (Supplementary Tables 3, 4) .
Sensitivity analyses relaxing the LD threshold used to define LD blocks yielded fewer LD blocks (e.g., for the full set of 16 GWAS, n=58 at an R 2 threshold of 0.70), but did not alter the loci identified as genomewide significant or replicated in the original analyses.
PART 2. COMPARING THE 3-STAGE APPROACH GRSS TO THE TOP-HITS AND BEST-GUESS GRSS
To construct and test our GRSs, we followed-up the LD blocks identified in our 3-stage approach analyses in the GWAS dataset from the Atherosclerosis Risk in Communities (ARIC) Study. This dataset is publicly available through the National Institutes of Health Database of Genotypes and Phenotypes (dbGaP) (http://www.ncbi.nlm.nih.gov/gap, phs000090.v1.p1) and is described in the Data section of the main text.
We selected SNPs in the ARIC database to include in our two GRSs as follows: We defined tag SNPs for each of the LD blocks as SNPs that were in LD with every seed contained in the block at R 2 ≥0.95. We then matched 1 tag SNP per LD block with a SNP in the ARIC study genotype database that met the GENEVA ARIC Project Team's quality control criteria (GENEVA ARIC Project 2009). If no tag SNPs in an LD block could be matched in the ARIC database, we relaxed the LD threshold used to define a tag SNP until either a) the resulting set of tag SNPs overlapped with tag SNPs that we had already matched in the ARIC database, or b) a match with a new SNP in the ARIC database was achieved. These analyses yielded a set of n=28 SNPs from the subset of 9 GWAS and a set of n=57 SNPs from the full set of 16
GWAS.
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To compute the 3-stage approach GRSs for each ARIC participant, we (1) identified the obesityassociated allele for each SNP from the GWAS where that SNP was reported; (2) calculated the mean number of risk alleles at each locus; and (3) summed these means across loci to produce the 3-stage approach genome-wide scores.
To compute the top-hits and best-guess approach GRSs, we selected SNPs from the ARIC database to match SNPs from 3 published GRSs Speliotes et al. 2010) and the full set of obesity-associated SNPs listed in the NHGRI GWAS catalog for GWAS of Europeandescent samples. In cases where a specific SNP was not available in the ARIC database, we selected its closest LD proxy. We then summed obesity-associated alleles across each set of selected SNPs to create the comparison genome-wide scores.
To test if the 3-stage approach could construct a GRS that was at least as predictive of BMI and obesity as GRSs created with the top-hits and best-guess approaches, we compared effect sizes for different GRSs using the ARIC data. All GRSs were standardized to have mean=0 and standard deviation=1. To measure GRS effect sizes for BMI, we estimated Pearson correlations (r) from separate linear regressions of BMI on each of the GRSs. To measure GRS effect sizes for obesity, we estimated odds ratios (OR) from separate logistic regressions of obesity on each of the GRSs. Regression models were adjusted for age (linear and quadratic terms), gender, the age-gender interaction, and the ARIC Study Centers where data were collected (hereafter these statistical adjustments are described as "demographics and geography"). To test differences between GRS effect sizes, we conducted F-tests (for effect sizes estimated from linear regressions) and Wald tests (for effect sizes estimated from logistic regressions). For these tests, models including each of the GRSs being compared were jointly estimated using the seemingly unrelated regression method. Seemingly unrelated regression is a statistical approach for comparing coefficients from non-nested regression models (Baltagi 1980; Verzilli, Stallard, and Whittaker 2005) . Effect sizes were similar for all GRSs. Statistical tests indicated that our 3-stage approach GRSs performed as well as or better than GRSs created using top-hits and best-guess approaches (Supplementary Table 5 ). Thus, the 3-stage approach produced a GRS that was at least as predictive as top-hits and best guess approach GRSs. We used the 3-stage approach GRS created from the full set of 16 GWAS (hereafter the "Obesity GRS") in subsequent analyses.
Refining the 3-Stage Approach GRS for Obesity. SNPs at each locus to identify the "lead-SNP", the SNP with the strongest association, and the worstassociated SNP. We then compared the effect size for the lead-SNP to the effect sizes for the worstassociated SNP and for the mean number of risk alleles across SNPs at the locus. These analyses asked 1)
whether there was any difference in the signal from the different SNPs in a correlated set; and 2) whether a single SNP could provide an adequate summary of obesity-associated variation at the locus.
Models were fitted using linear regression with statistical adjustment for demographics and geography.
We compared effect sizes using the seemingly unrelated regression method (Baltagi 1980; Verzilli, Stallard, and Whittaker 2005) . Supplementary Table 6 shows results from this analysis. At all loci, the lead SNP, worst-associated SNP, and mean number of risk alleles performed similarly, with the exception of the FTO locus, at which the lead SNP rs9939609 performed slightly better than the worstassociated SNP rs1477196. Finally, we tested whether including multiple SNPs at a locus improved the prediction of BMI in a regression model. Analyses were conducted using the variable selection algorithm in the Stata program mfp (Royston and Ambler 1999) . Details of this method are reported elsewhere (Royston and Sauerbrei 2003) . Briefly, SNPs were added to a baseline model predicting BMI as a function of age, sex, and geography in order of decreasing statistical significance of the SNPs' bivariate association with BMI. SNPs were retained in the model if their inclusion resulted in a statistically significant (p<0.05) decrease in model deviance. Results showed that model fit was not improved by the inclusion of multiple SNPs at any locus. Therefore, we retained only the best-associated SNPs from each of the 7 loci, resulting in a 32-SNP GRS (Supplementary Table 7) .
PART 3. SENSITIVITY ANALYSES TO TEST HETEROGENEITY IN GRS ASSOCIATIONS
We tested the linearity of GRS-BMI associations using quadratic and cubic specifications of the GRS in linear regression models. Coefficients for the higher order (i.e. squared and cubic) GRS terms were not statistically significant (p>0.10 for all), indicating that the GRS-BMI association was approximately linear. We tested the measurement specificity of GRS-BMI associations by comparing GRS effect sizes for BMI to GRS effect sizes for weight and for waist circumference using the seemingly unrelated regression method (Baltagi 1980) . GRS coefficients were similar across all three models Supplement to Development & Evaluation of a Genetic risk score for Obesity DW Belsky et al.
(p>0.10 for tests of differences), indicating that the GRS predicted not just BMI, but related measures of body size and adiposity. We tested the whether GRS-BMI associations were different for men and women or for older as compared to younger individuals using product terms in linear regression models.
Coefficients for product terms were not statistically significant (p>0.10 for all), indicating that GRS-BMI associations were similar for men and women and across early to late mid-life. Finally, we tested whether GRS-BMI associations differed across the 4 in-person assessments in the ARIC Study using the seemingly unrelated regression method. GRS effect sizes were similar across all 4 assessments (p>0.10 for all comparisons), indicating that GRS-BMI associations were consistent across measurement intervals.
Supplementary Table 1. Genome Wide Association Studies Included In 3-Stage Approach Analyses.
GWAS information comes from the NHGRI GWAS Catalog (www.genome.gov). Risk SNPs were defined as any SNP associated with an obesity-related phenotype (BMI, weight, waist circumference, categorical obesity) at p<10 -5 in the discovery or combined discovery and replication samples of the GWAS. *Italicized counts include imputed genotypes; **Lindgren et al. also investigated associations with waist circumference, and these are the association tests included in the SNP selection analysis; ***Scherag et al. also investigated associations with BMI and both phenotypes were included in the SNP selection analysis. Citations for the GWAS are included as (Cotsapas et al. 2009; Fox et al. 2007; Frayling et al. 2007; Heard-Costa et al. 2009; Herbert et al. 2006; Hinney et al. 2007; Johansson et al. 2010; Lindgren et al. 2009; Liu et al. 2010; Liu et al. 2008; Loos et al. 2008; Meyre et al. 2009; Scherag et al. 2010; Scuteri et al. 2007; Speliotes et al. 2010; Willer et al. 2009 To measure obesity effect sizes for the GRSs, we estimated odds ratios (OR) from separate logistic regressions of obesity on each of the GRSs. Regression models were adjusted for age (linear and quadratic terms), gender, the age-gender interaction, and the ARIC Study Centers where data were collected. In Panel A, the Best-Guess GRS was based on the GRS published by Li and colleagues ) and the TopHits GRS was based on the GRS published by Peterson and colleagues . In Panel B, the Best Guess GRS was based on the full set of obesity-and BMI-associated SNPs listed in the NHGRI GWAS Catalog and the Top-Hits GRS was based on the GRS published by Speliotes and colleagues Supplementary Table 7 Footnote: GWAS replications include GWAS reporting any SNP in any LD block tagged by the SNP as obesity-associated at p<1x10 -5 in the discovery or combined discovery and replication samples. Test allele and other allele are reported from the positive strand. Effect-size weights were obtained from ) for all SNPs with the exception of rs867559, for which the effect size weight was obtained from ). Allele frequencies and per-allele effects are reported based on all participants in the analysis sample. Per-allele effects were estimated from linear regressions of BMI on SNP genotype (number of minor alleles), adjusted for demographics and geography. P-values are reported based on heteroskedasticity robust standard errors. collected. The regression model was specified to include linear and quadratic terms for age and a product term modeling interaction between age and sex. The simple genetic risk assessment (SNPs in FTO and downstream of MC4R) is a component of the weighted obesity genomic risk score. Thus, model m3 contains all of the information in model m2 as well as information from the remaining 30 SNPs included in the GRS. The 5 categories of socioeconomic status were modeled as dichotomous variables and were allowed to vary by sex in their relationship with obesity and BMI. Values of R 2 were estimated using linear regression models adjusted for demographic and geographic information. Percentile-based confidence intervals were generated using the bootstrap method. AUCs and percentile-based confidence intervals were estimated from ROC curves constructed for predicted values generated using a probit regression model and were adjusted for the ARIC Study Center where data were collected using Pepe's method ). IDIs and test statistics were estimated only for comparisons of models m3 and m2 and models m5 and m4 using Pencina's Method . IDIs for comparisons of models m2 and m3 with model m1 are identical to those reported for the respective obesity risk measures in 
